Efficacy and Safety of Dotinurad in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Iqbal, Ayman; Iqbal, Kinza; Farid, Eisha; Ishaque, Ali; Hasanain, Muhammad; Bin Arif, Taha; Arshad Ali, Shajeea; Rathore, Sawai Singh; Malik, Mehreen

Iqbal, Ayman; Iqbal, Kinza; Farid, Eisha; Ishaque, Ali; Hasanain, Muhammad; Bin Arif, Taha; Arshad Ali, Shajeea; Rathore, Sawai Singh; Malik, Mehreen.

Afiliação

Iqbal A; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Iqbal K; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Farid E; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Ishaque A; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Hasanain M; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Bin Arif T; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Arshad Ali S; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Rathore SS; Internal Medicine, Dr. Sampurnanand Medical College, Jodhpur, IND.
Malik M; Anesthesiology, Aga Khan University, Karachi, PAK.

Cureus ; 13(4): e14428, 2021 Apr 12.

Article em En | MEDLINE | ID: mdl-33996294

Palavras-chave

dotinurad; fyu-981; hyperuricemia; selective urate reabsorption inhibitor; urat1 inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google